As WellCore’s CFO, Bill is responsible for creating and managing the strategic financial plan, including executing key finance agreements, identifying and engaging new vendors and strategic partners as well as overseeing the management of those vital relationships. Prior to joining Team WellCore in June 2021, Bill served as CFO of Low T Center, a men’s-focused national Hormone Replacement Therapy clinic as well as serving as CFO of HerKare, a women’s-focused regional HRT and aesthetics clinic network. During his time at LTC and HK, Bill helped the company transition into a self-inject, at-home model, as well as an expansion of additional services, which was critical to the company’s weathering of the pandemic. Before making the leap into healthcare, Bill held other C-Level roles in the real estate and commercial banking sectors, consulting with the United States Treasury Department on the liquidation, divesture and management of structured acquisition transactions, representing over $1 billion in global at-risk balances associated with failing financial institutions insured by the FDIC. Bill holds a BS in Business and MBA from Lousiana State University and is recorded in the 2012 U.S. Congressional Record for notable Asset and Capital Market-related work product on behalf of the United States.